Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on May 13, 2013, detailing several significant events. The company amended and restated its credit agreement, increasing its unsecured revolving credit facility to $450 million with an option to extend it up to $600 million, with a maturity date extended to May 8, 2018. This provides enhanced financial flexibility for general corporate purposes. The report also announced the retirement of its Chief Financial Officer, Merilee Raines, and the interim appointment of Willard R. Blanche Jr. as acting CFO and Jeffery D. Chadbourne as acting Principal Accounting Officer. Additionally, the company's annual stockholder meeting results are provided, showing the election of directors, approval of executive compensation, amendments to the stock incentive plan, and ratification of the independent auditor.
Key Highlights
- 1IDXX amended and restated its credit agreement, increasing the revolving credit facility to $450 million (with an option to increase to $600 million) and extending the maturity to May 8, 2018.
- 2The new credit facility is unsecured and available for general corporate purposes, indicating improved financial flexibility.
- 3The company's CFO, Merilee Raines, retired, and interim appointments for CFO and Principal Accounting Officer were made.
- 4Willard R. Blanche Jr. was appointed acting CFO, and Jeffery D. Chadbourne was appointed acting Principal Accounting Officer.
- 5Stockholders elected all three director nominees, approved executive compensation on a non-binding basis, and approved amendments to the 2009 Stock Incentive Plan.
- 6PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the fiscal year 2013.
- 7The report signifies a proactive approach to capital management and organizational transition.